Sotabase

Career

· Co-founder, GOOD Marketing Company
· Jobwell
· OpenAI
· Rockset
· Postdoctoral Researcher, UCLA
· Graduate Student, University of California, Berkeley
· PhD Student, University of California, Berkeley

Publications (166)

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
New England Journal of Medicine · 2020
520
cited
Reusability is FIRRTL ground: Hardware construction languages, compiler frameworks, and transformations
2017 IEEE/ACM International Conference on Computer-Aided Design (ICCAD) · 2017
172
cited
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion.
Blood · 2014
164
cited
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
Nature Medicine · 2023
115
cited
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.
Blood Advances · 2020
100
cited
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
Journal of Clinical Oncology · 2021
98
cited
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
Cancer Cell · 2022
77
cited
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations
British Journal of Haematology · 2018
63
cited
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
Leukemia · 2022
58
cited
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.
Blood Advances · 2020
57
cited
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
Haematologica · 2020
50
cited
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies
Bone Marrow Transplantation · 2019
50
cited
Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.
Blood · 2017
42
cited
Autotuning Sparse Matrix-Vector Multiplication for Multicore
2012
41
cited
Bridging Radiation Rapidly and Effectively Cytoreduces High Risk Relapsed/Refractory Aggressive B-Cell Lymphomas Prior to Chimeric Antigen Receptor T-Cell Therapy.
Transplantation and Cellular Therapy · 2022
41
cited
Anemia in General Medical Inpatients Prolongs Length of Stay and Increases 30-Day Unplanned Readmission Rate
Southern medical journal (Birmingham, Ala. Print) · 2013
38
cited
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults.
Blood Advances · 2019
34
cited
Relapse after allogeneic stem cell transplantation of acute myeloid leukemia and myelodysplastic syndrome and importance of second cellular therapy.
Transplantation and Cellular Therapy · 2021
34
cited
A Phase II Study of Prophylactic Anakinra to Prevent CRS and Neurotoxicity in Patients Receiving CD19 CAR T Cell Therapy for Relapsed or Refractory Lymphoma
Blood · 2021
33
cited
Allogeneic hematopoietic cell transplantation for older patients.
Hematology. American Society of Hematology. Education Program · 2021
32
cited
Sotabase
Richard Lin | Researcher Profile | Sotabase | Sotabase